Amrize is trading at $37.09, down 7.34% in pre-market after its October 28, 2026, earnings release lowered full-year revenue guidance. - The outlook was reduced to $12.2–$12.4 billion, citing continued cost inflation and elevated interest rates. - Third-quarter revenue was $3.771 billion, missing analyst expectations, while adjusted EPS beat consensus. - The lower outlook and revenue miss appear to be the clearest company-specific explanation for the decline; available price context does not include trading volume.